KFF Health News’ ‘What the Health?’: American Health Under Trump — Past, Present, and Future

The Host Emmarie Huetteman KFF Health News @emmarieDC Emmarie Huetteman, senior editor, oversees a team of Washington reporters, as well as “Bill of the Month” and KFF Health News’ “What the Health?” She previously spent more than a decade reporting on the federal government, most recently covering surprise medical bills, drug pricing reform, and other health policy…

Read More

California Medicaid Ballot Measure Is Popular, Well Funded — And Perilous, Opponents Warn

The proponents of Proposition 35, a November ballot initiative that would create a dedicated stream of funding to provide health care for California’s low-income residents, have assembled an impressive coalition: doctors, hospitals, community clinics, dentists, ambulance companies, several county governments, numerous advocacy groups, big business, and both major political parties. The Yes on Prop 35…

Read More

Some hopeful trends on opioid overdoses (finally)

While opioid overdoses have been rising for decades, trends in most recent times provide us a glimmer of hope. NPR reports: For the first time in decades, public health data shows a sudden and hopeful drop in drug overdose deaths across the U.S.“This is exciting,” said Dr. Nora Volkow, head of the National Institute On…

Read More

Unpacking the FDA’s Non-Recall Recalls

When the Agriculture Department posted a recall of chicken nuggets that might be contaminated, it directed consumers to return them or throw the stuff away. When the Consumer Product Safety Commission announced that poorly designed baby loungers could suffocate babies, it warned consumers to immediately stop using them. But when it comes to medical devices,…

Read More

California May Regulate and Restrict Pharmaceutical Brokers

SACRAMENTO, Calif. — California Gov. Gavin Newsom will soon decide whether the most populous U.S. state will join 25 others in regulating the middlemen known as pharmacy benefit managers, or PBMs, whom many policymakers blame for the soaring cost of prescription drugs. PBMs have been under fire for years for alleged profiteering and anticompetitive conduct,…

Read More